JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cameron, C. E.
Right arrow Articles by Weber, I. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cameron, C. E.
Right arrow Articles by Weber, I. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 268, Issue 16, 11711-11720, Jun, 1993

Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases

CE Cameron, B Grinde, P Jacques, J Jentoft, J Leis, A Wlodawer and IT Weber
Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-4935.

A steady state kinetic analysis of the avian myeloblastosis virus/Rous sarcoma virus (AMV/RSV) and human immunodeficiency virus Type 1 (HIV-1) retroviral proteases (PRs) was carried out using a series of 40 peptide substrates that are derivatives of the AMV/RSV nucleocapsid-PR cleavage site. These peptides contain single amino acid substitutions in each of the seven positions of the minimum length substrate required by the PR for specific and efficient cleavage. These peptide substrates are distinguished by the individual enzyme subsites of the AMV/RSV and HIV- 1 PRs. The molecular basis for similarities and differences of the individual subsites for both proteases is discussed using steady state kinetic data and modeling based on crystal structures.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
T. Sperka, G. Miklossy, Y. Tie, P. Bagossi, G. Zahuczky, P. Boross, K. Matuz, R. W. Harrison, I. T. Weber, and J. Tozser
Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases
J. Gen. Virol., July 1, 2007; 88(7): 2052 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Bagossi, T. Sperka, A. Feher, J. Kadas, G. Zahuczky, G. Miklossy, P. Boross, and J. Tozser
Amino Acid Preferences for a Critical Substrate Binding Subsite of Retroviral Proteases in Type 1 Cleavage Sites
J. Virol., April 1, 2005; 79(7): 4213 - 4218.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. C. Pettit, G. J. Henderson, C. A. Schiffer, and R. Swanstrom
Replacement of the P1 Amino Acid of Human Immunodeficiency Virus Type 1 Gag Processing Sites Can Inhibit or Enhance the Rate of Cleavage by the Viral Protease
J. Virol., September 11, 2002; 76(20): 10226 - 10233.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Xiang, R. Thorick, M. L. Vana, R. Craven, and J. Leis
Proper Processing of Avian Sarcoma/Leukosis Virus Capsid Proteins Is Required for Infectivity
J. Virol., July 1, 2001; 75(13): 6016 - 6021.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. W. Schatz, J. Reinking, J. Zippin, L. K. Nicholson, and V. M. Vogt
Importance of the N Terminus of Rous Sarcoma Virus Protease for Structure and Enzymatic Function
J. Virol., May 15, 2001; 75(10): 4761 - 4770.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Tozser, P. Bagossi, I. T. Weber, J. M. Louis, T. D. Copeland, and S. Oroszlan
Studies on the Symmetry and Sequence Context Dependence of the HIV-1 Proteinase Specificity
J. Biol. Chem., July 4, 1997; 272(27): 16807 - 16814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. W. Ridky, D. Bizub-Bender, C. E. Cameron, I. T. Weber, A. Wlodawer, T. Copeland, A. M. Skalka, and J. Leis
Programming the Rous Sarcoma Virus Protease to Cleave New Substrate Sequences
J. Biol. Chem., May 3, 1996; 271(18): 10538 - 10544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Józ. Tözsér, Pét. Bagossi, I. T. Weber, T. D. Copeland, and S. Oroszlan
Comparative Studies on the Substrate Specificity of Avian Myeloblastosis Virus Proteinase and Lentiviral Proteinases
J. Biol. Chem., March 22, 1996; 271(12): 6781 - 6788.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. W. Ridky, C. E. Cameron, J. Cameron, J. Leis, T. Copeland, A. Wlodawer, I. T. Weber, and R. W. Harrison
Human Immunodeficiency Virus, Type 1 Protease Substrate Specificity Is Limited by Interactions between Substrate Amino Acids Bound in Adjacent Enzyme Subsites
J. Biol. Chem., March 1, 1996; 271(9): 4709 - 4717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ridky and J. Leis
Development of Drug Resistance to HIV-1 Protease Inhibitors
J. Biol. Chem., December 15, 1995; 270(50): 29621 - 29623.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1993 by the American Society for Biochemistry and Molecular Biology.